The Australian: Penington Institute cautions against overly strict cannabis regulation
The Australian recently reported that doctors have criticised medicinal cannabis companies for pushing to assess drug safety based on patient experiences rather than rigorous clinical trials. This comes amid an independent review by the Therapeutic Goods Administration on medicinal cannabis prescriptions, which has highlighted tensions between cautious medical professionals and profit-driven cannabis businesses. Penington Institute […]
Australia’s medical lobby groups failing to take a ‘wider view’ on cannabis questions
Some leading Australian medical bodies are failing to take account of wider public health considerations in debates about medicinal cannabis access and reform. In response to a Federal Government-commissioned review into medicinal cannabis, groups including the Australian Medical Association have called for an immediate halt to the prescribing and dispensing of most medicinal cannabis products. […]